xMAP Technology

Luminex Corporation develops, manufactures and markets proprietary biological testing technologies with applications throughout the diagnostics and life sciences industries. The Company’s xMAP® multiplex solutions include an open architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics markets. The Company’s xMAP technology is sold worldwide and is already is use in leading clinical laboratories as well as major pharmaceutical, diagnostic and biotechnology companies. Further information on Luminex Corporations or xMAP can be obtained at www.luminexcorp.com